Literature DB >> 20412375

Medical and surgical management of reproductive neoplasia in two western lowland gorillas (Gorilla gorilla gorilla).

Elizabeth M Stringer1, Ryan S De Voe, Fidel Valea, Sameh Toma, Gerald Mulvaney, Amy Pruitt, Brigid Troan, Michael R Loomis.   

Abstract

BACKGROUND: Reports of female reproductive tract neoplasia are infrequent in great apes.
METHODS: Two captive-born, female western lowland gorillas (Gorilla gorilla gorilla) housed at the North Carolina Zoological Park were diagnosed with reproductive neoplasia.
RESULTS: The first gorilla had uterine endometrial thickening and uterine fibroids diagnosed during a routine annual examination. Subsequently, the animal underwent several uterine curettage procedures in an attempt to debulk the uterine mass. Biopsy results indicated uterine adenocarcinoma. The animal was treated with an ovariohysterectomy followed by a combination of megestrol acetate and medroxyprogesterone acetate. The second gorilla was diagnosed with squamous cell carcinoma of the vagina, cervix, and uterus after presenting for intermittent vaginal bleeding of 1-month duration. This animal underwent palliative radiation therapy, receiving two rounds of radiation treatment 8 weeks apart.
CONCLUSIONS: The following report describes the diagnosis and management of the two cases.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2010        PMID: 20412375     DOI: 10.1111/j.1600-0684.2010.00414.x

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  2 in total

1.  Diagnosis and prevalence of uterine leiomyomata in female chimpanzees (Pan troglodytes).

Authors:  E N Videan; W C Satterfield; S Buchl; M L Lammey
Journal:  Am J Primatol       Date:  2011-03-25       Impact factor: 2.371

Review 2.  The occurrence of cancer in vertebrates: a mini review.

Authors:  Christos V Kitsoulis; Athanasios D Baxevanis; Theodore J Abatzopoulos
Journal:  J Biol Res (Thessalon)       Date:  2020-06-08       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.